Background illustration for clinical trials search

Paid Clinical Trials Idaho

Discover 289 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 289

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

for

Growth Hormone Deficiency

Location: Manchester NH, Lebanon NH, New Hyde Park NY,

Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 0+

Code: NCT05820672

Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for

Metastatic Head and Neck Squamous Cell Carcinoma,

Location: Boston MA, Saint Johnsbury VT, Lebanon NH, Commack NY,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase3, Recruiting

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

for

Uterine Fibroids, Endometriosis

Location: West New York NJ, Philadelphia PA, Virginia Beach VA,

Sponsor: Sumitomo Pharma Switzerland GmbH

Sex: Female

Age: 18 - 50

Code: NCT05862272

Phase3, Recruiting

PerQdisc Traditional Feasibility Trial.

for

Discogenic Low Back Pain

Location: Carmel IN, Shreveport LA, Coeur d'Alene ID,

Sponsor: Spinal Stabilization Technologies

Sex: All

Age: 22 - 70

Code: NCT06860867

Recruiting

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

for

Advanced Lung Non-Squamous Non-Small Cell Carcinoma,

Location: Worcester MA, Waterford CT, Guilford CT, Glastonbury CT,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT04181060

Phase3, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for

Lung Non-Small Cell Carcinoma

Location: Brewer ME, Gloucester MA, Beverly MA, Peabody MA,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT06116682

Phase2, Recruiting

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

for

Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum

Location: Scarborough ME, Boston MA, Jamaica Plain MA,

Sponsor: NRG Oncology

Sex: All

Age: 45 - 70

Code: NCT05080673

Recruiting

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

for

Metastatic Malignant Neoplasm in the Liver,

Location: Westerly RI, Waterford CT, Guilford CT, Glastonbury CT,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05040360

Phase2, Recruiting

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

for

Heart Failure

Location: St. John's, Sydney, Halifax, Moncton, Saint John,

Sponsor: AstraZeneca

Sex: All

Age: 40+

Code: NCT06677060

Phase3, Recruiting

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

for

Malignant Female Reproductive System Neoplasm,

Location: Brewer ME, Augusta ME, Scarborough ME, Providence RI,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06126276

Phase2, Recruiting

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

for

Acute Leukemia of Ambiguous Lineage,

Location: Scarborough ME, Boston MA, Providence RI, Worcester MA,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 0 - 1

Code: NCT06317662

Phase2, Recruiting

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

for

Cystic Fibrosis

Location: Boston MA, Worcester MA, New Hyde Park NY, Valhalla NY,

Sponsor: Nicole Hamblett

Sex: All

Age: 12+

Code: NCT06504589

Recruiting

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

for

Bladder Adenocarcinoma, Bladder Clear Cell Adenocarcinoma,

Location: Peabody MA, Burlington MA, Commack NY, Uniondale NY,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03866382

Phase2, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for

NonSegmental Vitiligo

Location: St. John's, Halifax, Boston MA, Quebec, Woodbury NY,

Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase3, Recruiting

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

for

Pleural Biphasic Mesothelioma, Pleural Sarcomatoid Mesothelioma

Location: Raleigh NC, Durham NC, Jacksonville FL, Danville IL,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT05647265

Phase2, Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

for

Clear Cell Renal Cell Carcinoma, Renal Cell Carcinoma (RCC),

Location: Brewer ME, Gloucester MA, South Weymouth MA, Beverly MA,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06661720

Phase3, Recruiting

FeaturedActive & Responsive

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

for

Hypothyroidism

Location: Boston MA, Dracut MA, Nashua NH, Smithtown NY,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06345339

Phase2, Phase3, Recruiting

Featured

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

for

Crohn's Disease

Location: New Bedford MA, New Haven CT, Quebec, Danbury CT,

Sponsor: AbbVie

Sex: All

Age: 18 - 70+

Code: NCT06548542

Phase2, Recruiting

Featured

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

for

Atopic Dermatitis

Location: Quincy MA, Boston MA, New Haven CT, Lebanon NH, Quebec,

Sponsor: AbbVie

Sex: All

Age: 18 - 63

Code: NCT06389136

Phase3, Recruiting

Pre-Operative Ketamine Infusion for Post Operative Pain Control After Revision Spinal Surgery

for

Revision Spine Surgery, Fusion of Spine, Cervical Fusion,

Location: Coeur d'Alene ID

Sponsor: AXIS Spine Center- a division of Northwest Specialty Hospital

Sex: All

Age: 18 - 70+

Code: NCT06066879

Recruiting

Popular cities in Idaho

Idaho Falls Meridian Boise

Paid Clinical Trials Idaho

Filter results

A US Non-interventional, Effectiveness and Safety Study of Patients Treated With SKYTROFA

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

PerQdisc Traditional Feasibility Trial.

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Interested in new trials?

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab

Pre-Operative Ketamine Infusion for Post Operative Pain Control After Revision Spinal Surgery

Popular cities in Idaho